DYNAVAX TECHNOLOGIES CP
			Symbol			DVAX

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

Dynavax to Report Third Quarter 2009 Financial Results after Market Closes on October 22, 2009

2009-10-21 16:36 ET - News Release

To Host Webcast of Conference Call

BERKELEY, Calif. -- (Business Wire)

Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it plans to report third quarter 2009 financial results after the market closes on Thursday, October 22, 2009.

The Company also plans to host a webcast of a conference call on Thursday, October 22, 2009 at 4:30 pm EDT (1:30 pm PDT). To access the live audio webcast and the subsequent archived audio recording of the presentation, please log onto Dynavax’s website at http://investors.dynavax.com/newsevents.cfm.

About Dynavax

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. The Company's lead product candidate is HEPLISAV^TM, a Phase 3 investigational adult hepatitis B vaccine designed to provide more rapid and increased protection with fewer doses than current licensed vaccines. For more information visit www.dynavax.com.

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.